REAL INTELLIGENCE CORI (CORI)

K212537 · Blue Belt Technologies, Inc. · OLO · Nov 3, 2021 · Neurology

Device Facts

Record IDK212537
Device NameREAL INTELLIGENCE CORI (CORI)
ApplicantBlue Belt Technologies, Inc.
Product CodeOLO · Neurology
Decision DateNov 3, 2021
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 882.4560
Device ClassClass 2
AttributesTherapeutic

Intended Use

REAL INTELLIGENCE CORI (CORI) is intended to assist the surgeon in providing software-defined spatial boundaries for orientation and reference information to anatomical structures during orthopedic procedures.

Device Story

CORI is a computer-assisted orthopedic surgical navigation and burring system used in hospital/clinical settings by surgeons. It utilizes a passive infrared tracking camera to track instruments and reference arrays. For knee procedures, it generates image-free/non-CT models of femur/tibia to create surgical plans; it provides software-defined spatial boundaries to control surgical bur engagement or limit bone removal. For hip procedures, it incorporates Brainlab HIP7 software to determine pelvic/femoral landmarks and implant orientation, enabling intraoperative measurement of leg length and offset. The system includes a virtual machine with a hypervisor to host the hip navigation software. Surgeons use the system to guide implant placement, potentially improving accuracy and patient outcomes. The device can operate in a robotic-assisted mode or as a standard navigated drill.

Clinical Evidence

No clinical data. Evidence consists of bench testing, including design verification and validation, software integration testing per IEC 62304, and usability engineering validation in a simulated use environment.

Technological Characteristics

Stereotaxic instrument; passive infrared tracking camera; robotic console/cart; virtual machine with hypervisor; USB 2.0 to Ethernet adapter. Complies with IEC 60601-1-2 (EMC). Software developed per IEC 62304.

Indications for Use

Indicated for surgical procedures where stereotactic surgery is appropriate and rigid anatomical bony structures can be referenced. Procedures include unicondylar knee replacement (UKR), total knee arthroplasty (TKA), and total hip arthroplasty (THA). Knee applications are indicated for use with cemented implants only.

Regulatory Classification

Identification

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ November 3, 2021 Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo in blue, with the words "U.S. FOOD & DRUG ADMINISTRATION" in blue as well. The FDA is a federal agency responsible for regulating and supervising the safety of food, drugs, and other products. Blue Belt Technologies, Inc. Sarah Plittman Regulatory Affairs Specialist II 2905 Northwest Blvd., Ste. 40 Plymouth, Minnesota 55441 Re: K212537 Trade/Device Name: REAL INTELLIGENCE CORI (CORI) Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: August 10, 2021 Received: August 12, 2021 Dear Sarah Plittman: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. For Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ### Indications for Use 510(k) Number (if known) K212537 Device Name REAL INTELLIGENCE CORI (CORI) Indications for Use (Describe) CORI is indicated for use in surgical procedures, in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony structures can be determined. These procedures include unicondylar knee replacement (UKR), total knee arthroplasty (THA). For Knee applications, CORI is indicated for use with cemented implants only. Type of Use (Select one or both, as applicable) | <span style="font-family: DejaVu Sans, sans-serif">✘</span> Prescription Use (Part 21 CFR 801 Subpart D) | <span style="font-family: DejaVu Sans, sans-serif">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) | |----------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------| |----------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------| ### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. ### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo consists of a blue swirl design on the left, followed by the words "BLUE BELT" in large, bold, blue letters. Below "BLUE BELT" is the word "TECHNOLOGIES" in smaller, gray letters. The logo is simple and modern, and the use of blue and gray gives it a professional look. 2905 Northwest Boulevard, Suite 40, Plymouth, Minnesota 55441 USA Tel 763.452.4950 Fax 763.452.4675 www.bluebelttech.com # 510(k) Summary (K212537) | 510(k) Owner | Blue Belt Technologies, Inc.<br>2905 Northwest Blvd Ste. 40<br>Plymouth, MN 55441 USA<br>Tel: (763) 452-4950<br>Fax: (763) 452-4675 | |--------------------------|-------------------------------------------------------------------------------------------------------------------------------------| | Contact Person | Sarah Plittman<br>Regulatory Affairs Specialist II<br>Tel: 423-838-4454<br>Email: sarah.plittman@smith-nephew.com | | Date of Submission | 08/10/2021 | | Classification Reference | 21 CFR 882.4560 | | Product Code | OLO | | Common/Usual Name | Orthopedic Stereotaxic Instrument | | Trade/Proprietary Name | REAL INTELLIGENCE® CORI® (CORI) | | Primary Predicate Device | REAL INTELLIGENCE® CORI® (CORI) (K201022) | | Reference Device | Brainlab AG HIP7 (K193307) | | Reason for Submission | New Indication | {4}------------------------------------------------ Image /page/4/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo features a stylized blue swirl on the left, followed by the words "BLUE BELT" in large, bold, blue letters. Below "BLUE BELT" is the word "TECHNOLOGIES" in smaller, gray letters. ### Intended Use REAL INTELLIGENCE CORI (CORI) is intended to assist the surgeon in providing software-defined spatial boundaries for orientation and reference information to anatomical structures during orthopedic procedures. ### Indications for Use CORI is indicated for use in surgical procedures, in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony structures can be determined. These procedures include unicondylar knee replacement (UKR), total knee arthroplasty (TKA) and total hip arthroplasty (THA). For Knee applications, CORI is indicated for use with cemented implants only. ### Device Description CORI is a computer-assisted orthopedic surgical navigation and surgical burring system. CORI uses established technologies of navigation, via a passive infrared tracking camera. For robotic knee applications, CORI software can control the cutting engagement of the surgical bur based on its proximity to the planned target surface. Alternatively, the surgeon can disable both controls and operate the robotic drill as a standard navigated surgical drill. For the hip navigation application, CORI incorporates the Brainlab HIP7 software (K193307) which will be market by Smith & Nephew as RI.HIP NAVIGATION. It uses instruments and reference arrays, which are tracked by the IR camera, to determine pelvis and femur anatomical landmarks as well as implant orientation. RI.HIP NAVIGATION assists the orientation of prosthetic hip implants and enables measurement of leg length and offset when used intraoperatively in combination with CORI. {5}------------------------------------------------ Image /page/5/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo consists of a blue swirl design on the left, followed by the words "BLUE BELT" in large, blue, sans-serif font. Below "BLUE BELT" is the word "TECHNOLOGIES" in a smaller, gray, sans-serif font. The logo is clean and modern, with a focus on the company name. ## Discussion of Similarities and Differences The subject device, CORI, is substantially equivalent to the predicate device CORI (K201022). For knee applications, functionality of the subject device is the same as the predicate device. Functionality has been added to support the THA application. | Devices | Subject Device<br>REAL INTELLIGENCE CORI [K212537] | Predicate Device<br>REAL INTELLIGENCE CORI [K201022] | |---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Intended use | Same as Predicate. | REAL INTELLIGENCE CORI (CORI) is intended<br>to assist the surgeon in providing software-<br>defined spatial boundaries for orientation<br>and reference information to anatomical<br>structures during orthopedic procedures. | | Indications for Use | CORI is indicated for use in surgical procedures,<br>in which the use of stereotactic surgery may be<br>appropriate, and where reference to rigid<br>anatomical bony structures can be determined.<br><br>These procedures include unicondylar knee<br>replacement (UKR), total knee arthroplasty<br>(TKA), and total hip arthroplasty (THA).<br><br>For knee applications, CORI is indicated for use<br>with cemented implants only. | CORI is indicated for use in surgical knee<br>procedures, in which the use of stereotactic<br>surgery may be appropriate, and where<br>reference to rigid anatomical bony<br>structures can be determined.<br><br>These procedures include unicondylar knee<br>replacement (UKR) and total knee<br>arthroplasty (TKA).<br><br>CORI is indicated for use with cemented<br>implants only. | | Contraindications | Same as Predicate for UKR and TKA. | CORI is not intended to be used on<br>children, pregnant women, patients who<br>have mental or neuromuscular disorders<br>that do not allow control of the knee joint,<br>morbidly obese patients, or any other<br>patients contraindicated for knee<br>replacement. | | Anatomical Site | The subject device is intended for knee and hip<br>joint replacement surgery. | The CORI system is intended for knee joint<br>replacement surgery only. | Table 1: Summary of Technological Similarities with Predicate {6}------------------------------------------------ Image /page/6/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo consists of a blue swirl design on the left, followed by the words "BLUE BELT" in large, blue, sans-serif font. Below "BLUE BELT" is the word "TECHNOLOGIES" in a smaller, gray, sans-serif font. The overall design is clean and modern. 2905 Northwest Boulevard, Suite 40, Plymouth, Minnesota 55441 USA Tel 763.452.4950 Fax 763.452.4675 www.bluebelttech.com | Devices | Subject Device<br>REAL INTELLIGENCE CORI [K212537] | Predicate Device<br>REAL INTELLIGENCE CORI [K201022] | |------------------------------------------------------------|----------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Environment of Use | Same as Predicate. | CORI is intended to be used by trained<br>medical professionals in a hospital or<br>clinical setting equivalent to an<br>orthopedic surgery suite. | | Energy Used | Same as Predicate. | Rated Supply Voltage:<br>100-240 V ~, 50/60 Hz<br>Robotics Console Power Rating: 175VA<br>Robotics Cart Power Rating: 230VA | | Compatibility with<br>the Environment<br>and Other Devices | Same as Predicate. | 60601-1-2 Edition 4.0 2014-02 Medical<br>Electrical Equipment – Part 1-2: General<br>Requirements for Basic Safety and Essential<br>Performance – Collateral Standard:<br>Electromagnetic Compatibility -<br>Requirements and Tests. | ReshapingMobility™ {7}------------------------------------------------ Image /page/7/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo consists of a blue swirl design on the left, followed by the words "BLUE BELT" in large, blue, sans-serif font. Below "BLUE BELT" is the word "TECHNOLOGIES" in a smaller, gray, sans-serif font. The overall design is clean and modern. 2905 Northwest Boulevard, Suite 40, Plymouth, Minnesota 55441 USA Tel 763.452.4950 Fax 763.452.4675 www.bluebelttech.com | Devices | Subject Device<br>REAL INTELLIGENCE CORI [K212537] | Predicate Device<br>REAL INTELLIGENCE CORI [K201022] | |----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Technological<br>Characteristics | Same as Predicate for UKR and TKA with the<br>following additions:<br><br>The subject device adds a Virtual Machine with<br>hypervisor to enable the Windows-based HIP7<br>software to run on CORI.<br><br>The subject device adds a new USB 2.0 to<br>Ethernet Adapter that will attach to the CORI<br>console. The USB 2.0 to Ethernet Adapter willVirtual Machine when using the Hip<br>application. | CORI uses established technologies to<br>prepare bone for attachment of UKR and<br>TKA implant components. In the case of a<br>total knee arthroplasty, the bone surface<br>may also be prepared to receive the<br>femoral and tibial cutting guides.<br><br>CORI uses intraoperative data collection<br>(image-free or non-CT data generation) to<br>create a model of the patient's femur<br>and/or tibia, dependent on the procedure<br>being performed, and allows the surgeon<br>to prepare a surgical plan.<br><br>CORI uses predefined boundaries<br>generated during the planning process to<br>control the motion of the surgical bur and<br>limit the amount of bone removed in order<br>to shape the condyles or tibial plateau in<br>preparation for placement of the surgical<br>implant.<br><br>During a TKA procedure, the surgeon may<br>choose to prepare the bone surface for<br>receiving the implant using the Bur All<br>method or the bone surface is prepared to<br>receive the femoral and tibial cutting<br>guides with final bone surface for receiving<br>the implant prepared using a standard<br>surgical saw.<br><br>Bur cutting is controlled either by retracting<br>the bur in a guard, or by controlling the<br>speed of the bur as the target surface is<br>approached. | Brainlab HIP7 (K193307) is being listed as a reference device because the subject device is incorporating the HIP7 software and instruments cleared in K193307 to support its new THA indication. The Brainlab HIP7 software and instruments are unchanged from those previously cleared in K193307. There is no change to the HIP7 intended use, indications for use, technological characteristics, or instrumentation as a result of including the HIP7 software on the subject device. {8}------------------------------------------------ Image /page/8/Picture/0 description: The image shows the logo for Blue Belt Technologies. The logo consists of a blue swirl design on the left, followed by the words "BLUE BELT" in large, blue, sans-serif font. Below "BLUE BELT" is the word "TECHNOLOGIES" in a smaller, gray, sans-serif font. The overall design is clean and modern. ## Non-Clinical Testing (Bench) Design verification and validation tests were performed on CORI to demonstrate that the changes presented in this submission meet all design input requirements and that CORI is as safe and effective as its predicate device. Refer to Section 11: Summary of Design Control Activities for the results of the testing performed. Additionally, the following testing was conducted: • Software Integration Testing was completed. Software was developed in accordance with IEC 62304 Medical device software - Software life cycle processes, and this submission contains documentation per the requirements of FDA's Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices. • Usability Engineering Validation Testing demonstrating that representative users were able to safely and effectively use CORI with the THA application in a simulated use environment. No human clinical testing was required to determine the safety and effectiveness of CORI. ### Conclusions The subject device, CORI, described in this submission has the same intended use and the similar technological characteristics as the predicate device, CORI (K201022). The primary difference between the subject device and CORI (K201022) is the addition of the THA indication supported by HIP7 software, the Virtual Machine, and the optional USB 2.0 to Ethernet Connector. The THA application incorporates HIP7 software (reference device K193307) onto CORI via a virtual machine. The indications for use, functionality, and technological characteristics of the HIP7 software are the identical as presented in K193307. The HIP7 software, and the instrumentation necessary to complete a THA navigation procedure, remains unchanged from what was cleared in K193307. Performance testing of these minor differences has demonstrated that the subject device is substantially equivalent to the predicate device (K201022) and that these differences raise no new questions of safety or effectiveness. The subject device continues to meet design requirements, is as safe and effective as its predicate device, and performs according to its intended use. The information presented in this 510(k) premarket notification demonstrates that the subject device is substantially equivalent and as safe and effective as the predicate, CORI (K201022). Blue Belt Technologies believes that FDA can find the subject device to be substantially equivalent to the predicate device.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%